Retroperitoneal sarcomas are a rare group of malignant soft tissue tumors with a generally poor prognosis. The aim of the study was to assess clinical, pathological and treatment-related factors affecting prognosis in patients with retroperitoneal sarcomas.
Methods and Study Design
The hospital records of 73 patients who underwent surgical exploration at our unit for primary retroperitoneal sarcomas between 1984 and 2003 were reviewed. Factors influencing overall and disease-free survival were analyzed for all patients and for those who underwent complete surgical resection.
Results
The complete resectability rate was 69.8% (51/73). Operative mortality and morbidity rates were 2.7% and 21.9%, respectively. For patients who underwent complete resection, the 5-year survival rate was 58.3%, whereas it was 0% in cases of incomplete or no resection (P <0.001). Local recurrence rate was 37.2%. Incomplete gross surgical resection and microscopic infiltration of margins were the most important independent predictors of a poor prognosis.
Conclusions
The present study confirmed the importance of an aggressive surgical management for retroperitoneal sarcomas to offer these patients the best chance for long-term survival.
PorterG.A., BaxterN.N., PistersP.W.T.: Retroperitoneal Sarcoma. A population based-study analysis of epidemiology, surgery, and radiotherapy.Cancer, 106: 1610–1615, 2006.
Van DalenT., HennipmanA., Van CoevordenF., HoekstraH.J., Van GeelB.N., SlootwegP., LutterC.F., BrennanM.F., SingerS.: Evaluation of a clinically applicable post-surgical classification system for primary retroperitoneal soft-tissue sarcoma.Ann Surg Oncol, 11: 483–490, 2004.
AlvarengaJ.C., BallA.B.S., FisherC., FryattI., JonesL., ThomasJ.M.: Limitations of surgery in the treatment of retroperitoneal sarcoma.Br J Surg, 78: 912–916, 1991.
9.
KarakousisC.P., VelezA.F., EmrichL.J.: Management of retroperitoneal sarcomas and patient survival.Am J Surg, 150: 376–380, 1985.
10.
DaltonR.R., DonohueJ.H., MuchaP.Jr., Van HeerdenJ.A., ReimanH.M., ChenS.P.: Management of retroperitoneal sarcomas.Surgery, 106: 725–733, 1989.
11.
GronchiA., CasaliP.G., FioreM., MarianiL., LoVulloS., BertulliR., ColecchiaM., LazzoL., OlmiP., SantinamiM., RosaiJ.: Retroperitoneal soft tissue sarcomas. Patterns of recurrence in 167 patients treated at a single institution.Cancer, 100: 2448–2455, 2004.
12.
HassanI., ParkS.Z., DonohueJ.H., NagorneyD.M., KayP.A., NasciementoA.G., SchleckC.D., IlstrupD.M.: Operative management of primary retroperitoneal sarcomas. A reappraisal of an institutional experience.Ann Surg, 239: 244–250, 2004.
BradleyJ.C., CaplanR.: Giant retroperitoneal sarcoma: a case report and review of the management of retroperitoneal sarcomas.Am Surg, 68: 52–56, 2002.
15.
LewisJ.J., LeungD., WoodruffJ.M., BrennanM.F.: Retroperitoneal soft-tissue sarcoma. Analysis of 500 patients treated and followed at a single institution.Ann Surg, 228: 355–365, 1998.
16.
Van DalenT., PooijJ.M., Van CoevordenF., Van GeelB.N., HoekstraH.J., Albus-LutterC.H., SlootwegP.J., HennipmanA., Dutch Soft Tissue Sarcoma Group: Long-term prognosis of primary retroperitoneal soft tissue sarcoma.Eur J Surg Oncol, 33: 234–238, 2007.
17.
StoeckleE., CoindreJ.M., BonvalotS., KantorG., TerrierP., BonichenF., Nguyen BuiB., French Federation of Cancer Centers Sarcoma Group: Prognostic factors in retroperitoneal sarcoma. A multivariate analysis of a series of 165 patients of the French Cancer Center Federation Sarcoma Group.Cancer, 92: 359–368, 2001.
18.
NeuhausS.J., BarryP., ClarkM.A., HayesA.J., FisherC., ThomasJ.M.: Surgical management of primary and recurrent retroperitoneal liposarcoma.Br J Surg, 92: 246–252, 2005.
19.
RussoP., KimY., RavindranS., HuangW., BrennanM.F.: Nephrectomy during operative management of retroperitoneal sarcoma.Ann Surg Oncol, 4: 421–424, 1997.
20.
KarakousisC.P., ProimakisC., RaoU., VelezA.F., DriscollD.L.: Local recurrence and survival in soft-tissue sarcomas.Ann Surg Oncol, 3: 255–260, 1996.
21.
ErzenD., SencarM., NovakJ.: Retroperitoneal sarcoma: 25 years of experience with aggressive surgical treatment at the Institute of Oncology, Ljubljana.J Surg Oncol, 91: 1–9, 2005.
22.
KilkennyJWIII, BlandK.I., CopelandEMIII: Retroperitoneal sarcoma: the University of Florida experience.J Am Coll Surg, 3: 150–158, 1996.
23.
BonvalotS., VanelD., Le CesneA., TerrierP., Le PecheuxC.: Surgery of retroperitoneal sarcomas.Cancer Radiother, 10: 41–49, 2006.
HermanK., KusyT.: Retroperitoneal sarcoma – the continued challenge for surgery and oncology.Surg Oncol, 7: 77–81, 1999.
26.
PirayeshA., CheeY., HelliwellT.R., HershmanM.J., LeinsterS.J., FordhamM.V., PostonG.J.: The management of retroperitoneal soft tissue sarcoma: a single institution experience with a review of the literature.Eur J Surg Oncol, 27: 491–497, 2001.
27.
Van DalenT., HoekstraH.J., Van GeelA.N., Van CoevordenF., Albus-LutterC.H., SlootwegP.J., HennipmanA., Dutch Soft Tissue Sarcoma Group: Locoregional recurrence of retroperitoneal soft tissue sarcoma: second chance of cure for selected patients.Eur J Surg Oncol, 27: 564–568, 2001.
28.
PistersP.W., HarrisonL.B., LeungD.H., WoodruffJ.M., CasperE.S., BrennanM.F.: Long-term results of a prospective randomized trial of adjuvant brachytherapy in soft tissue sarcoma.J Clin Oncol, 14: 859–868, 1996.
29.
SindelarW.F., KinsellaT.J., ChenP.W., DeLaneyT.F., TepperJ.E., RosenbergS.A., GlatsteinE.: Intraoperative radiotherapy in retroperitoneal sarcoma. Final results of a prospective, randomized, clinical trial.Arch Surg, 128: 402–410, 1993.
